Vinge advised Active Biotech on its rights offering

Vinge advised Active Biotech AB (publ) in connection with its rights offering.

Vinge has advised Carrier in connection with the sale of its remaining stake in Beijer Ref

Carrier Global Corporation (“Carrier”) is a leading global provider of heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation technologies, and is listed on the New York Stock Exchange. Beijer Ref AB (publ) (“Beijer Ref”) provides commercial and industrial refrigeration as well as heating and air conditioning products and is listed on Nasdaq Stockholm.

Vinge has advised Gränges in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin)

Vinge has advised Gränges AB (publ) in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin).

Vinge advises Fidelio Capital in connection with its acquisition of Premune AB (publ)'s ownership in Nextmune AB

Vinge advises Athanase on its public offer for IVISYS

Athanase Industrial Partners II KB has made a public mandatory bid for all shares in IVISYS AB.

Vinge has advised Deutsche Börse in connection with its acquisition of Institutional Shareholder Services Inc.

Vinge has advised Deutsche Börse, one of the world’s largest operators of marketplaces for securities trading, in the Swedish part of the acquisition of a majority holding amounting to approximately 80% of Institutional Shareholder Services Inc., a leading provider of ESG data, steering and analysis to investors.

Vinge advises SBB on its offer for Entra

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer to the shareholders of Entra ASA.

Vinge advises on the sale of Word Audio Publishing International

Vinge has advised the sellers in connection with the sale of Word Audio Publishing International AB to Danish Gyldendal A/S

Vinge advised Investindustrial on its acquisition of Carl von Linnékliniken Group.

Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.

Vinge advises Re:NewCell on its IPO

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Market.

Vinge has advised Gränges in connection with its rights issue

Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximately SEK 1.7 billion before transaction costs.

Vinge represents the owners of AppInConf Holding AB (“AppInConf”) in connection with the sale of the company to Invajo Techonlogies AB (publ) (“Invajo”)

AppInConf develops and provides mobile digital solutions for events and meetings and has historically been strong against e.g. medtech industry.

Vinge has advised VEF Ltd in connection with a directed share issue

Vinge has advised VEF Ltd, an investment company whose Swedish Depositary Receipts (“SDR”) are listed on Nasdaq First North, in connection with a directed share issue whereby VEF receives approximately SEK 522 million in issue proceeds.

Vinge has advised Nextory in connection with capital raising

Nextory has acquired SEK 165 million in a capital raising.

Vinge advises Main Capital in connection with the acquisition of PointSharp AB

PointSharp provides security solutions which enable enterprises to secure the login of their users to all their applications through e.g. multi-factor authentication, with a simplified user experience. PointSharp serves more than 220 customers globally.